| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
: A Role for Bcl-21
Departments of Medicine [S. W. T., K. D., D. C. P., B. A. A.] and Pharmacology [M. K. B., A. E.], Dartmouth Medical School, Hanover, New Hampshire 03755
Transforming growth factor ß (TGF-ß) is a multifunctional cytokine
capable of regulating diverse cellular processes. In this study we
investigated the effect of autocrine TGF-ß signaling on tumor
necrosis factor (TNF)
-induced cell death. We abrogated the TGF-ß
autocrine loop by overexpression of a truncated TGF-ß type II
receptor in MCF-7 breast carcinoma cells and found that this generated
resistance to TNF-
-induced cytotoxicity. To elucidate the molecular
basis of the influence of TGF-ß on TNF-
-induced cytotoxicity, we
evaluated the expression levels or activities of proteins involved in
TNF-
signal transduction or the regulation of apoptosis in general
in TGF-ß-responsive and TGF-ß-nonresponsive MCF-7 cells. We
observed no significant difference in the expression of TNF-
receptors or the TNF receptor-associated death domain protein. In
addition, downstream activation of nuclear factor
B by TNF-
was
not altered in cells that had lost TGF-ß responsiveness. Analysis of
members of the Bcl-2 family of apoptosis-regulatory proteins revealed
that Bcl-XL and Bax expression levels were not changed by
disruption of TGF-ß signaling. In contrast, the TGF-ß-nonresponsive
cells expressed much higher levels of Bcl-2 protein and mRNA than did
cells with an intact TGF-ß autocrine loop. Furthermore, restoration
of a TGF-ß signal to MCF-7 cells that had spontaneously acquired
resistance to TGF-ß caused a reduction in Bcl-2 protein expression.
Taken together, our data indicate that loss of autocrine TGF-ß
signaling results in enhanced resistance to TNF-
-mediated cell death
and that this is likely to be mediated by derepression of Bcl-2
expression.
This article has been cited by other articles:
![]() |
D N Danforth Jr All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor {beta} to stimulate apoptosis in MCF-7 breast cancer cells J. Endocrinol., November 1, 2004; 183(2): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jeruss, C. D. Sturgis, A. W. Rademaker, and T. K. Woodruff Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer Cancer Res., July 1, 2003; 63(13): 3783 - 3790. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |